Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2023 Mar;130(3):e11-e12.
doi: 10.1016/j.ophtha.2022.10.018. Epub 2022 Nov 25.

Re: Tomar et al.: American Joint Committee on Cancer Ophthalmic Oncology Task Force. High-risk pathologic features based on presenting findings in advanced intraocular retinoblastoma: a multicenter, international data-sharing American Joint Committee on Cancer Study (Ophthalmology. 2022;129:923-932) and Tomar et al.: American Joint Committee on Cancer Ophthalmic Oncology Task Force. Metastatic death based on presenting features and treatment for advanced intraocular retinoblastoma: a multicenter registry-based study. (Ophthalmology. 2022;129:933-945)

David H Abramson  1 , Carol L Shields  2
Affiliations
Multicenter Study

Re: Tomar et al.: American Joint Committee on Cancer Ophthalmic Oncology Task Force. High-risk pathologic features based on presenting findings in advanced intraocular retinoblastoma: a multicenter, international data-sharing American Joint Committee on Cancer Study (Ophthalmology. 2022;129:923-932) and Tomar et al.: American Joint Committee on Cancer Ophthalmic Oncology Task Force. Metastatic death based on presenting features and treatment for advanced intraocular retinoblastoma: a multicenter registry-based study. (Ophthalmology. 2022;129:933-945)

David H Abramson et al. Ophthalmology. 2023 Mar.
No abstract available

PubMed Disclaimer

Comment on

  • High-risk Pathologic Features Based on Presenting Findings in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing American Joint Committee on Cancer Study.
    Tomar AS, Finger PT, Gallie B, Kivelä TT, Mallipatna A, Zhang C, Zhao J, Wilson MW, Brennan RC, Burges M, Kim J, Berry JL, Jubran R, Khetan V, Ganesan S, Yarovoy A, Yarovaya V, Kotova E, Volodin D, Yousef YA, Nummi K, Ushakova TL, Yugay OV, Polyakov VG, Ramirez-Ortiz MA, Esparza-Aguiar E, Chantada G, Schaiquevich P, Fandino A, Yam JC, Lau WW, Lam CP, Sharwood P, Moorthy S, Long QB, Essuman VA, Renner LA, Semenova E, Català-Mora J, Correa-Llano G, Carreras E; American Joint Committee on Cancer Ophthalmic Oncology Task Force. Tomar AS, et al. Ophthalmology. 2022 Aug;129(8):923-932. doi: 10.1016/j.ophtha.2022.04.006. Epub 2022 Apr 15. Ophthalmology. 2022. PMID: 35436535 Free PMC article.
  • Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multicenter Registry-Based Study.
    Tomar AS, Finger PT, Gallie B, Kivelä TT, Mallipatna A, Zhang C, Zhao J, Wilson MW, Brennan RC, Burges M, Kim J, Berry JL, Jubran R, Khetan V, Ganesan S, Yarovoy A, Yarovaya V, Kotova E, Volodin D, Yousef YA, Nummi K, Ushakova TL, Yugay OV, Polyakov VG, Ramirez-Ortiz MA, Esparza-Aguiar E, Chantada G, Schaiquevich P, Fandino A, Yam JC, Lau WW, Lam CP, Sharwood P, Moorthy S, Long QB, Essuman VA, Renner LA, Semenova E, Català-Mora J, Correa-Llano G, Carreras E; American Joint Committee on Cancer Ophthalmic Oncology Task Force. Tomar AS, et al. Ophthalmology. 2022 Aug;129(8):933-945. doi: 10.1016/j.ophtha.2022.04.022. Epub 2022 Apr 30. Ophthalmology. 2022. PMID: 35500608 Free PMC article.

LinkOut - more resources